Migraine Therapeutic Market, By Therapeutics (Pain-relieving Medications and Preventive Medications), By Route of Administration (Oral and Nasal and Injection), and By Geography (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Mar 2025

Code : CMI575

Pages :165

Formats :

Excel and PDF

Industry : Pharmaceutical

Leading Companies

Global Migraine Therapeutic Market: Key Companies Insights

Some of the key players in the global migraine therapeutic market are:

Pfizer Inc., Novartis International AG, Merck & Co. Inc., GlaxoSmithKline PLC, Eli Lilly and Company, AstraZeneca PLC, Amgen Inc., Allergan Inc., Bausch Health Companies Inc., and Teva Pharmaceutical Industries Ltd., among others.